I

Researcher Profile

Ivan Sinielnikov

🏛 37Volyn Regional Oncology Center, Ukraine;

3

Publications

2,797

Citations

10

Co-Authors

2

Active Years

Publications

Journal Article Cancer Research May 02, 2024

Abstract GS01-03: Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy: interim analysis of the ALEXANDRA/IMpassion030 phase 3 trial

Michail Ignatiadis · Andrew Bailey · Heather McArthur · Sarra El-Abed +45 more

10.1158/1538-7445.sabcs23-gs01-03 12 citations

Journal Article Journal of Clinical Oncology Jul 01, 2024

RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

David R. Spigel · Afshin Dowlati · Yuanbin Chen · Alejandro Navarro +118 more

10.1200/jco.23.02110 32 citations

Journal Article The Lancet May 01, 2019

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony S K Mok · Yi-Long Wu · Iveta Kudaba · Dariusz M Kowalski +246 more

10.1016/s0140-6736(18)32409-7 2,753 citations

Publication Timeline

2024

2

2019

1

Frequent Co-Authors

Yaroslav Shparyk

Mahmut Gümüş

Andrzej Kazarnowicz

Fabio Andre Franke